title: [Significance of serum determination of beta-HCG in patients with breast cancer].
authors: A
authors: A
authors: Tolino
authors: C
authors: C
authors: Di Serio
authors: G
authors: G
authors: Borruto Caracciolo
authors: S
authors: S
authors: Giamberini
authors: A
authors: A
authors: Giuliano
authors: U
authors: U
authors: Montemagno
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood* / Q000628:therapy; D002277:Carcinoma / Q000097:blood* / Q000628:therapy; D006063:Chorionic Gonadotropin / Q000097:blood*; D018997:Chorionic Gonadotropin, beta Subunit, Human; D005260:Female; D006801:Humans; D008875:Middle Aged; D010446:Peptide Fragments / Q000097:blood*; D013997:Time Factors
chemical_list: D014408:Biomarkers, Tumor; D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human; D010446:Peptide Fragments
vernacular_title: Significato del dosaggio sierico della beta-HCG in pazienti affette da cancro della mammella.